199 related articles for article (PubMed ID: 20667051)
1. Operational evaluation of a service for prevention of mother-to-child transmission of HIV in rural Uganda: barriers to uptake of single-dose nevirapine and the role of birth reporting.
Barigye H; Levin J; Maher D; Tindiwegi G; Atuhumuza E; Nakibinge S; Grosskurth H
Trop Med Int Health; 2010 Oct; 15(10):1163-71. PubMed ID: 20667051
[TBL] [Abstract][Full Text] [Related]
2. Non-adherence to the single dose nevirapine regimen for the prevention of mother-to-child transmission of HIV in Bindura town, Zimbabwe: a cross-sectional analytic study.
Kuonza LR; Tshuma CD; Shambira GN; Tshimanga M
BMC Public Health; 2010 Apr; 10():218. PubMed ID: 20426830
[TBL] [Abstract][Full Text] [Related]
3. In-home HIV testing and nevirapine dosing by traditional birth attendants in rural Zambia: a feasibility study.
Brennan AT; Thea DM; Semrau K; Goggin C; Scott N; Pilingana P; Botha B; Mazimba A; Hamomba L; Seidenberg P
J Midwifery Womens Health; 2014; 59(2):198-204. PubMed ID: 24106818
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY).
Onyango-Makumbi C; Omer SB; Mubiru M; Moulton LH; Nakabiito C; Musoke P; Mmiro F; Zwerski S; Wigzell H; Falksveden L; Wahren B; Antelman G; Fowler MG; Guay L; Jackson JB
J Acquir Immune Defic Syndr; 2011 Dec; 58(4):399-407. PubMed ID: 21826009
[TBL] [Abstract][Full Text] [Related]
5. Missed Opportunities along the Prevention of Mother-to-Child Transmission Services Cascade in South Africa: Uptake, Determinants, and Attributable Risk (the SAPMTCTE).
Woldesenbet S; Jackson D; Lombard C; Dinh TH; Puren A; Sherman G; Ramokolo V; Doherty T; Mogashoa M; Bhardwaj S; Chopra M; Shaffer N; Pillay Y; Goga A;
PLoS One; 2015; 10(7):e0132425. PubMed ID: 26147598
[TBL] [Abstract][Full Text] [Related]
6. Determinants of nonadherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Rwanda.
Delvaux T; Elul B; Ndagije F; Munyana E; Roberfroid D; Asiimwe A
J Acquir Immune Defic Syndr; 2009 Feb; 50(2):223-30. PubMed ID: 19131884
[TBL] [Abstract][Full Text] [Related]
7. Outcome of different nevirapine administration strategies in preventing mother-to-child transmission (PMTCT) programs in Tanzania and Uganda.
Karcher H; Kunz A; Poggensee G; Mbezi P; Mugenyi K; Harms G
MedGenMed; 2006 Apr; 8(2):12. PubMed ID: 16926751
[TBL] [Abstract][Full Text] [Related]
8. Uptake and performance of prevention of mother-to-child transmission and early infant diagnosis in pregnant HIV-infected women and their exposed infants at seven health centres in Addis Ababa, Ethiopia.
Girma M; Wendaferash R; Shibru H; Berhane Y; Hoelscher M; Kroidl A
Trop Med Int Health; 2017 Jun; 22(6):765-775. PubMed ID: 28407452
[TBL] [Abstract][Full Text] [Related]
9. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
10. The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009.
Namukwaya Z; Mudiope P; Kekitiinwa A; Musoke P; Matovu J; Kayma S; Salmond W; Bitarakwate E; Mubiru M; Maganda A; Galla M; Byamugisha J; Fowler MG
J Acquir Immune Defic Syndr; 2011 Jan; 56(1):69-75. PubMed ID: 21099692
[TBL] [Abstract][Full Text] [Related]
11. Current status of medication adherence and infant follow up in the prevention of mother to child HIV transmission programme in Addis Ababa: a cohort study.
Mirkuzie AH; Hinderaker SG; Sisay MM; Moland KM; Mørkve O
J Int AIDS Soc; 2011 Oct; 14():50. PubMed ID: 22017821
[TBL] [Abstract][Full Text] [Related]
12. Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand.
Lallemant M; Le Coeur S; Sirirungsi W; Cressey TR; Ngo-Giang-Huong N; Traisathit P; Klinbuayaem V; Sabsanong P; Kanjanavikai P; Jourdain G; Mcintosh K; Koetsawang S;
AIDS; 2015 Nov; 29(18):2497-507. PubMed ID: 26372485
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of repeat single-dose nevirapine for prevention of mother-to-child transmission of HIV-1 in repeat pregnancies in Uganda.
McConnell M; Bakaki P; Eure C; Mubiru M; Bagenda D; Downing R; Matovu F; Thigpen MC; Greenberg AE; Fowler MG
J Acquir Immune Defic Syndr; 2007 Nov; 46(3):291-6. PubMed ID: 18167645
[TBL] [Abstract][Full Text] [Related]
14. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
[TBL] [Abstract][Full Text] [Related]
15. Prevention of mother-to-child transmission of HIV infection: views and perceptions about swallowing nevirapine in rural Lilongwe, Malawi.
O'Gorman DA; Nyirenda LJ; Theobald SJ
BMC Public Health; 2010 Jun; 10():354. PubMed ID: 20565930
[TBL] [Abstract][Full Text] [Related]
16. WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.
Ciaranello AL; Perez F; Maruva M; Chu J; Engelsmann B; Keatinge J; Walensky RP; Mushavi A; Mugwagwa R; Dabis F; Freedberg KA;
PLoS One; 2011; 6(6):e20224. PubMed ID: 21655097
[TBL] [Abstract][Full Text] [Related]
17. Comparing two service delivery models for the prevention of mother-to-child transmission (PMTCT) of HIV during transition from single-dose nevirapine to multi-drug antiretroviral regimens.
Tsague L; Tsiouris FO; Carter RJ; Mugisha V; Tene G; Nyankesha E; Koblavi-Deme S; Mugwaneza P; Kayirangwa E; Sahabo R; Abrams EJ
BMC Public Health; 2010 Dec; 10():753. PubMed ID: 21134259
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.
Ngemu EK; Khayeka-Wandabwa C; Kweka EJ; Choge JK; Anino E; Oyoo-Okoth E
BMC Res Notes; 2014 Jan; 7():52. PubMed ID: 24447387
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and challenges of scaling up comprehensive PMTCT services in rural Swaziland, Southern Africa.
Bancheno WM; Mwanyumba F; Mareverwa J
AIDS Care; 2010 Sep; 22(9):1130-5. PubMed ID: 20824565
[TBL] [Abstract][Full Text] [Related]
20. Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial.
Aliyu MH; Blevins M; Audet CM; Kalish M; Gebi UI; Onwujekwe O; Lindegren ML; Shepherd BE; Wester CW; Vermund SH
Lancet HIV; 2016 May; 3(5):e202-11. PubMed ID: 27126487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
